Immediate Impact
2 by Nobel laureates 24 from Science/Nature 74 standout
Citing Papers
Cancer biomarkers: Emerging trends and clinical implications for personalized treatment
2024 Standout
Immune checkpoint therapy—current perspectives and future directions
2023 StandoutNobel
Works of Yan V. Wang being referenced
A phase Ib/II study of the anti-CD47 antibody magrolimab with cetuximab in solid tumor and colorectal cancer patients.
2020
Atezolizumab, an Anti–Programmed Death-Ligand 1 Antibody, in Metastatic Renal Cell Carcinoma: Long-Term Safety, Clinical Activity, and Immune Correlates From a Phase Ia Study
2016 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Yan V. Wang | 271 | 522 | 159 | 253 | 8 | 859 | |
| Steven E. Kalloger | 226 | 342 | 65 | 312 | 9 | 755 | |
| Youn Choi Park | 606 | 539 | 157 | 58 | 13 | 1.0k | |
| AA Bartolucci | 165 | 240 | 222 | 186 | 20 | 851 | |
| Pamela Salman | 172 | 592 | 235 | 170 | 19 | 962 | |
| Jo Marie Tran Janco | 80 | 371 | 148 | 363 | 13 | 853 | |
| DavidA. Clark | 445 | 408 | 58 | 268 | 6 | 886 | |
| Mindert Krans | 88 | 217 | 225 | 97 | 19 | 1.0k | |
| Miller Ls | 106 | 447 | 137 | 121 | 9 | 1.0k | |
| Steve Gyorffy | 219 | 251 | 142 | 190 | 18 | 782 | |
| Huiying Piao | 195 | 439 | 123 | 97 | 10 | 1.1k |
All Works
Loading papers...